TGF-β-induced signaling circuit loops mediated by microRNAs as new therapeutic targets for renal fibrosis?

Kidney International

Volumn 84, Issue 6, 2013, Pages 1067-1069

  Kato, Mitsuo ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 433; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; URETER OBSTRUCTION;

ANIMALS; CARRIER PROTEINS; KIDNEY; KIDNEY DISEASES; MALE; MICRORNAS; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84888619056     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.297     Document Type: Note

References (12)

1. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney Int 2006; 69: 213-217.
2. Kato M, Natarajan R. MicroRNA circuits in transforming growth factor-beta actions and diabetic nephropathy. Semin Nephrol 2012; 32: 253-260.
3. Chandrasekaran K, Karolina DS, Sepramaniam S et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int 2012; 81: 617-627.
4. Kasinath BS, Feliers D. The complex world of kidney microRNAs. Kidney Int 2011; 80: 334-337.
5. Li R, Chung ACK, Dong Y et al. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-b/Smad3-Azin1 pathway. Kidney Int 2013; 84: 1129-1144.
6. Chung AC, Huang XR, Meng X et al. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 2010; 21: 1317-1325.
7. Liu L, Santora R, Rao JN et al. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2003; 285: G1056-G1067.
8. Deshpande SD, Putta S, Wang M et al. Transforming growth factor-b induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 2013; 62: 3151-3162.
9. Kato M, Arce L, Wang M et al. A microRNA circuit mediates transforming growth factorbeta1 autoregulation in renal glomerular mesangial cells. Kidney Int 2011; 80: 358-368.
10. Kato M, Dang V, Wang M et al. TGF-beta induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci Signal [online] 2013; 6: Ra43.
11. Cai X, Xia Z, Zhang C et al. Serum microRNAs levels in primary focal segmental glomerulosclerosis. Pediatr Nephrol 2013; 28: 1797-1801.
12. Sun L, Zhang D, Liu F et al. Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192. J Pathol 2011; 225: 364-377.